Lemon Bottle
Esta página aún no está disponible en tu idioma.
Lemon Bottle presents a product-identity conflict rather than a conventional injectable-product profile. SID MEDICOS states that its authentic Lemon Bottle Ampoule Solution is an external-use cosmetic and is not intended for lipolysis or injection. Swissmedic has separately investigated products carrying the Lemon Bottle name that were offered for injection and classified those presentations as unauthorized medicinal products in Switzerland.
The external-use product and an item sold as Lemon Bottle injection should not be assumed to have the same identity, composition, source, or intended route.
Quick reference
Section titled “Quick reference”| Field | What can be established |
|---|---|
| Named company | SID MEDICOS, Republic of Korea |
| Company position on authentic ampoule | Cosmetic for external use; not intended for lipolysis or injection |
| Swiss injectable-product status | Classified as a medicinal product requiring authorization; not authorized for distribution or use in Switzerland |
| Sample finding | Swissmedic did not detect the declared ingredients in samples obtained from different sources |
| Authenticity boundary | SID MEDICOS said it could not verify that the investigated samples were authentic |
| Core editorial role | Product authenticity, intended route, and regulatory-classification case |
Source: Swissmedic warning of March 26, 2024, with June 25, 2024 addendum 🔗.
Swissmedic’s regulatory finding
Section titled “Swissmedic’s regulatory finding”Swissmedic reported receiving increasing enquiries about Lemon Bottle products advertised online and through social media for localized fat reduction. Based on the represented composition and injection route, the Swiss cross-agency panel classified the lipolysis solution as a medicinal product.
Because no Swiss medicinal-product authorization existed, Swissmedic stated on March 26, 2024 that the product could not be placed on the Swiss market and should not be sold, dispensed, or used there. The authority also stated that no medicinal effect had been scientifically demonstrated.
This is a jurisdiction-specific legal finding. It supports unauthorized in Switzerland as a medicinal product offered for injection, not a universal statement about every product bearing the name in every country.
Laboratory and authenticity findings
Section titled “Laboratory and authenticity findings”Swissmedic tested samples obtained from different sources and reported that it could not detect the ingredients declared for the Lemon Bottle lipolysis solution. This raises at least three separate questions:
- whether the tested items were authentic
- whether their labeling accurately described their contents
- whether any product with that identity was legally authorized for injection
The laboratory result should not be rewritten as proof that every authentic SID MEDICOS cosmetic contains no declared ingredients. The authority’s addendum records that the distributor could not authenticate the investigated samples.
SID MEDICOS’ external-use position
Section titled “SID MEDICOS’ external-use position”In the June 25, 2024 addendum, Swissmedic records SID MEDICOS’ position that:
- it could not verify that the samples tested by Swissmedic were original products
- the original Lemon Bottle Ampoule Solution was exclusively an external-use cosmetic
- the original product was not intended for lipolysis or injection
- the packaging and leaflet carried external-use cosmetic wording
That response materially changes how the entity should be indexed. It does not turn injectable use into approved use; it instead separates the manufacturer’s stated cosmetic identity from products promoted or supplied for injection.
Product-name collision
Section titled “Product-name collision”The name Lemon Bottle may appear in several contexts:
| Context | Appropriate interpretation |
|---|---|
| SID MEDICOS external-use ampoule | Cosmetic identity described by the company |
| Product advertised as fat-dissolving injection | Injectable medicinal purpose requiring market-specific authorization |
| Unverified online vial or package | Identity, contents, route, and source unresolved |
| Lemon Bottle skin-care or skin-booster line | Separate presentation that should not inherit a lipolysis or injection identity |
For this reason, a package photograph, vial color, ingredient list copied from a seller, or the name alone is not enough to identify the product.
United States context
Section titled “United States context”In a March 3, 2025 warning letter, FDA told a US seller that its LemonBottle Ampoule Solution and several other products were being marketed with drug claims without approved applications. The letter treated the products’ claimed effects and intended use as drug claims under US law (FDA warning letter to Fox Pharma 🔗).
This describes the US promotion and distribution addressed in the letter. It should not be used to claim that FDA analyzed and authenticated every Lemon Bottle product worldwide.
Composition claims require source attribution
Section titled “Composition claims require source attribution”Online and promotional materials have associated Lemon Bottle with ingredients such as riboflavin, lecithin, bromelain, and other components. The Swissmedic findings show why such lists cannot be accepted without identifying the exact source and authentic product.
An external-use cosmetic ingredient list also does not establish:
- sterile manufacture
- suitability for injection
- a pharmacologic fat-reduction effect
- an approved anatomical indication
- equivalence to a deoxycholic-acid drug or PPC/deoxycholate mixture
Safety and practitioner boundary
Section titled “Safety and practitioner boundary”Products intended only for external cosmetic use should not be injected. A product offered for injection requires an identifiable authorization, legal manufacturer, sterile presentation, quality controls, labeling, and professional-use framework in the relevant jurisdiction.
If a patient presents after a Lemon Bottle injection, documentation should preserve the exact package, vial, lot, supplier, claimed ingredient list, route, treated area, timing, and remaining product when available. Do not assume that a reaction can be interpreted from the brand name alone.
Nearby reference pages
Section titled “Nearby reference pages”- Product and regulatory classification explains why cosmetic identity and injectable medicinal purpose are different legal questions.
- Regional regulation places the Swiss and US actions in their jurisdictions.
- Safety and treatment boundaries provides the sourcing and adverse-event documentation framework.